Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated Pruritus
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Pruritus is an essential feature for the diagnosis of atopic dermatitis and may play an
important part in disease progression. Itching has a significant impact on the quality of
life of AD sufferers, in particular night-time itching leading to sleep disturbance and
subsequent poor daytime performance.
The objective of this study is to determine whether SRD174 Cream is a safe and effective
therapy for moderate to severe pruritus associated with atopic dermatitis.